ADUS 📈 Addus HomeCare - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0067391062
ADUS: Personal Care, Hospice, Home Health
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas. Web URL: https://www.addus.com
Additional Sources for ADUS Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ADUS Stock Overview
Market Cap in USD | 2,227m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2009-10-28 |
ADUS Stock Ratings
Growth 5y | 36.6% |
Fundamental | 54.5% |
Dividend | - |
Rel. Strength Industry | 654 |
Analysts | 4.55/5 |
Fair Price Momentum | 128.87 USD |
Fair Price DCF | 180.33 USD |
ADUS Dividends
No Dividends PaidADUS Growth Ratios
Growth Correlation 3m | -54.3% |
Growth Correlation 12m | 88.4% |
Growth Correlation 5y | 29.5% |
CAGR 5y | 7.33% |
CAGR/Mean DD 5y | 0.35 |
Sharpe Ratio 12m | 1.10 |
Alpha | 10.87 |
Beta | 0.98 |
Volatility | 30.39% |
Current Volume | 473.7k |
Average Volume 20d | 171.7k |
What is the price of ADUS stocks?
As of December 21, 2024, the stock is trading at USD 131.40 with a total of 473,672 shares traded.
Over the past week, the price has changed by +5.12%, over one month by +8.60%, over three months by +0.74% and over the past year by +38.81%.
As of December 21, 2024, the stock is trading at USD 131.40 with a total of 473,672 shares traded.
Over the past week, the price has changed by +5.12%, over one month by +8.60%, over three months by +0.74% and over the past year by +38.81%.
Is Addus HomeCare a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Addus HomeCare (NASDAQ:ADUS) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.45 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADUS as of December 2024 is 128.87. This means that ADUS is currently overvalued and has a potential downside of -1.93%.
Partly, yes. Based on ValueRay Fundamental Analyses, Addus HomeCare (NASDAQ:ADUS) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.45 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADUS as of December 2024 is 128.87. This means that ADUS is currently overvalued and has a potential downside of -1.93%.
Is ADUS a buy, sell or hold?
Addus HomeCare has received a consensus analysts rating of 4.55. Therefor, it is recommend to buy ADUS.
Addus HomeCare has received a consensus analysts rating of 4.55. Therefor, it is recommend to buy ADUS.
- Strong Buy: 8
- Buy: 2
- Hold: 0
- Sell: 1
- Strong Sell: 0
What are the forecast for ADUS stock price target?
According to ValueRays Forecast Model, ADUS Addus HomeCare will be worth about 142.7 in December 2025. The stock is currently trading at 131.40. This means that the stock has a potential upside of +8.59%.
According to ValueRays Forecast Model, ADUS Addus HomeCare will be worth about 142.7 in December 2025. The stock is currently trading at 131.40. This means that the stock has a potential upside of +8.59%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 136.6 | 4% |
Analysts Target Price | 113.3 | -13.8% |
ValueRay Target Price | 142.7 | 8.6% |